Regenerative craniofacial implant manufacturer OssDsign has amassed $19.7m altogether as it prepares to take its products based on Karolinska and Uppsala university research into new markets.
OssDsign, a Sweden-based developer of regenerative implants founded on research from Karolinska University Hospital and Uppsala University, closed a SKr64m ($6.9m) private placement on Tuesday backed by investment manager Alto Invest.
The round also featured unnamed Swedish private investors.
Founded in 2011 as Oss-Q, OssDsign designs and manufactures healing implants for bone defects made from titanium and a calcium phosphate material that has regenerative properties.
Each OssDsign implant is custom-built for the individual patient through 3D printing…
